Press Releases

 Filter by Provider

CHICAGO, ILLINOIS / ACCESS Newswire / March 4, 2026 / (NYSE:KFS) Kingsway Financial Services Inc. ("Kingsway" or the "Company"), the only publicly-traded US company employing the Search Fund model to acquire and build great businesses, today announced that it will report financial results for the three and 12 months ended December 31, 2025, after the close of trading on Thursday, March 12, 2026.

REDMOND, WASHINGTON / ACCESS Newswire / March 4, 2026 / MicroVision, Inc. (NASDAQ:MVIS), defining the next generation of lidar-based perception solutions, today announced its fourth quarter and full year 2025 results.

LCI Industries (NYSE: LCII), a leading supplier of engineered components to the recreation and transportation markets, today announced its participation in three upcoming investor conferences, including the Loop Capital Markets 7th Annual Investor Conference on March 9th, the Wolfe Research Small Group Conference on March 17th, and the 38th Annual Roth Conference on March 23rd. Lillian Etzkorn, Chief Financial Officer, will host investor meetings throughout the day at all three events, joined by Jason Lippert, President & Chief Executive Officer, at the Roth Conference.

Pasqal Holding SAS (“Pasqal”), a global leader in neutral atom quantum computing, and Bleichroeder Acquisition Corp. II (“Bleichroeder”), a SPAC led and backed by Michel Combes and Andrew Gundlach (Nasdaq: BBCQ), announced today that they have entered into a definitive business combination agreement (“BCA”), following the consummation of which the go forward company will operate as Pasqal and is expected to be listed on Nasdaq. The proposed transaction is expected to close in the second half of 2026, subject to customary closing conditions, including regulatory and shareholder approval. As a global leader in neutral atom quantum computing, the deal values Pasqal at $2.0 billion pre-money, and contains $200 million in committed capital via convertible financing, which will allow Pasqal to deliver on its quantum roadmap and technology deployment, accelerate the Company’s efforts in demonstrating quantum advantage and accelerate international commercial and organizational growth.

When most Australians hear the word “quantum”, they think of something futuristic. A lab experiment. A distant breakthrough. Perhaps something to do with quantum computers...?

Amprius Technologies, Inc. ("Amprius" or the "Company") (NYSE: AMPX), a leader in next-generation lithium-ion batteries with its Silicon Anode Platform, today announced financial results for the fourth quarter and full year ended December 31, 2025, and discussed recent business developments.

American Eagle Outfitters, Inc. (NYSE: AEO) today announced financial results for the fourth quarter and fiscal year ended January 31, 2026, and provided its outlook for fiscal year 2026.

Stem, Inc. (“Stem,” “we,” or the “Company”) (NYSE: STEM), a global leader in clean energy software and services, today announced its financial results for the three and twelve months ended December 31, 2025.

ChargePoint Holdings, Inc. (NYSE:CHPT) (“ChargePoint”), a global leader in electric vehicle (EV) charging solutions, today reported results for its fourth quarter and full fiscal year 2026 ended January 31, 2026.

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological diseases, today reported financial results for the quarter and year-ended December 31, 2025, and recent corporate highlights.

Ironwood Pharmaceuticals, Inc. (Nasdaq: IRWD) today announced that management will participate in a fireside chat at The Citizens Life Sciences Conference on Wednesday, March 11th at 4:00 p.m. ET.

Savara Inc. (Nasdaq: SVRA) (the “Company”), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that members of the management team will participate in a fireside chat at the 2026 Citizens Life Sciences Conference on Wednesday, March 11th at 10:10am ET in Miami, FL.

J.B. Hunt Transport Services, Inc.’s (NASDAQ: JBHT) Executive Vice President and President of Intermodal Darren Field and Chief Financial Officer and Executive Vice President of Finance Brad Delco will address the J.P. Morgan Industrials Conference in Washington, D.C., at 9:30 a.m. EDT on Tuesday, March 17, 2026.

flyExclusive, Inc. (NYSEAMERICAN: FLYX), a leading provider of premium private jet experiences, announced it will release fourth quarter and full-year 2025 financial results through a Form 10-K to be filed with the Securities and Exchange Commission (SEC) before the market open on March 5, 2026. When filed, the Form 10-K can be found at https://ir.flyexclusive.com/sec-filings or at www.sec.gov. When filed, a supplemental presentation of fourth quarter and full-year results can also be found on the Financial Results section of our Investor Relations website here https://ir.flyexclusive.com/financial-information/financial-results.

Demonstrates 99.9% two-qubit gate fidelity at 28 nanosecond gate speed on prototype platform

Janus International Group, Inc. (NYSE: JBI) (“Janus” or the “Company”), a leading global manufacturer and provider of turnkey self-storage, commercial, and industrial building solutions, today announced financial results for its fiscal fourth quarter and full year ended January 3, 2026.

OmniAb, Inc. (NASDAQ: OABI) today reported financial results for the quarter and year ended December 31, 2025, and provided operating and partner program updates.

Universal Electronics Inc. (UEI) (NASDAQ: UEIC), the global leader in wireless universal control solutions for home entertainment and smart home devices, will host a conference call at 4:30 p.m. ET on Thursday, March 12, 2026, to discuss its fourth quarter 2025 financial results. Management will provide a financial and business update as well as answer questions.

WSFS Financial Corporation (Nasdaq: WSFS), the parent company of WSFS Bank, will participate in the 2026 RBC Capital Markets Global Financial Institutions Conference on March 11, 2026, in New York City. David Burg, Executive Vice President, Chief Financial Officer, Arthur J. Bacci, Executive Vice President, Chief Operating Officer, and Andrew Basile, Vice President, Head of Investor Relations will host discussions with investors.

CHAPEL HILL, N.C., March 04, 2026 (GLOBE NEWSWIRE) -- James River Group Holdings, Inc. ("James River" or the "Company") (NASDAQ: JRVR) today announced that Kelly Hadiaris has re-joined the Company as Senior Vice President, Underwriting – Excess Casualty, to lead the Excess Casualty division within its Excess and Surplus (“E&S”) segment. Ms. Hadiaris will report to Todd Sutherland, President of the E&S segment.

Refinancing Strengthens Capital Structure by Extending Debt Maturity and Providing Access to Additional Undrawn Capital

MENLO PARK, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- BillionToOne, Inc. (NASDAQ: BLLN), a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today reported its financial results for the fourth quarter and full year ended December 31, 2025 and raised guidance for full year 2026.

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in virtual care, today announced that it issued an inducement award to a new employee.

SAXONBURG, Pa., March 04, 2026 (GLOBE NEWSWIRE) -- Coherent Corp. (NYSE: COHR), a global leader in photonics, today announced the launch of its CHR1074 224Gbps quad-channel transimpedance amplifier (TIA) designed to power next-generation 800G and 1.6T optical transceivers. Engineered for high-performance AI and cloud infrastructure, the CHR1074 combines ultra-fast link recovery with intelligent power management to improve efficiency and reduce latency in increasingly dynamic data center environments.

Fourth Quarter Results

Fourth Quarter Revenue Increased 20% to a Record $23.4 Million

IRVINE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, and Steven Perrin, Ph.D., President and Chief Scientific Officer, will participate in a fireside chat at the upcoming Leerink Partners 2026 Global Healthcare Conference on Wednesday, March 11, 2026, at 1:40 p.m. ET (10:40 a.m. PT).

SAN DIEGO, March 04, 2026 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to bringing a first-in-class pipeline of induced pluripotent stem cell (iPSC)-derived cellular immunotherapies to patients with cancer and autoimmune diseases, today announced that on March 2, 2026, the Company granted restricted stock units (RSUs) representing 50,700 shares of its common stock to three newly-hired non-executive employees. The grants were approved by the Compensation Committee of the Company’s Board of Directors and granted under the Company’s Amended and Restated Inducement Equity Plan as an inducement material to the new employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4). The RSUs will vest over four years, with 25% of the shares underlying each RSU award vesting on each anniversary of the grant date, subject to the employees being continuously employed by the Company through each vesting date.

Free global platform provides healthcare professionals with 1,000+ premium courses and clinical images, including specialized training on AI-enhanced ultrasound diagnostics

MWC Barcelona 2026 offers a clear preview of what is coming next as artificial intelligence and 5G converge to reshape the wireless industry. Each year, global trade shows like Mobile World Congress in Barcelona usher in new thinking, fresh ideas, and breakthrough technologies for the wireless industry. In 2026, AI and 5G stand side by side, with powerful demonstrations of how they will transform both the industry and our everyday lives.

Smith Micro Software, Inc. (Nasdaq: SMSI) today announced that it has named current Chief Operating Officer and Chief Financial Officer Tim Huffmyer to serve as Smith Micro’s next President and Chief Executive Officer. Huffmyer will assume the role from Bill Smith, who has been appointed to the role of Executive Chairman. The changes will take effect on March 31, 2026 and follow leadership succession planning led by Smith and the Company’s Board of Directors.

PepGen Inc. (Nasdaq: PEPG), a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies to treat severe neuromuscular and neurological diseases, today announced regulatory updates related to the FREEDOM2 trial.

Niagen Bioscience, Inc. (NASDAQ:NAGE) today announced its fourth quarter and fiscal year 2025 financial results.

Cardlytics, Inc. (NASDAQ: CDLX) today announced financial results for the fourth quarter and full year ended December 31, 2025.

Smith Micro Software, Inc. (the “Company” or “Smith Micro”) (NASDAQ: SMSI) today announced that it has entered into a securities purchase agreement for the sale of securities to accredited investors pursuant to an unregistered offering, the gross proceeds of which are expected to be approximately $4.9 million, which includes committed investments of approximately $4.6 million from a trust for which Bill Smith, the Company’s chief executive officer and founder, serves as co-trustee, and approximately $90 thousand from Tim Huffmyer, the Company’s chief operating officer and chief financial officer.

Boynton Beach, FL - As homeowners across South Florida invest in home improvements that enhance both comfort and property value, experts at Sunline Kitchen Remodeling are encouraging residents to plan a professional Kitchen Remodel to modernize outdated kitchens and improve daily functionality. According to housing industry reports, kitchen renovations remain one of the most valuable home upgrades, often delivering some of the highest returns on investment among residential improvement projects.

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that Alexion Pharmaceuticals, Inc. (the “Licensee”) informed Xencor, Inc. (the “Company”) that it has taken the position that the Licensee does not owe any additional royalties for sales of Ultomiris® (ravulizumab-cwvz) in the United States and that the Licensee does not intend to make any future payments for sales in the United States. The Licensee informed the Company that it intends to continue making royalty payments for sales of Ultomiris outside the United States.

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the three months and full year ended December 31, 2025, and highlighted recent progress.

Magnachip Semiconductor Corporation (NYSE: MX) (“Magnachip” or the “Company”) today announced financial results for the fourth quarter and full year 2025.

Everspin Technologies, Inc. (NASDAQ: MRAM), the world’s leading developer and manufacturer of magnetoresistive random access memory (MRAM) persistent memory solutions, today announced preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025.

Smith Micro Software, Inc. (Nasdaq: SMSI) (“Smith Micro” or the “Company”) today reported financial results for its fourth quarter and fiscal year ended December 31, 2025.

Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company focused on developing FB102, which is a proprietary anti-CD122 monoclonal antibody therapeutic candidate with potentially broad autoimmune and autoimmune-related indications, today announced the issuance of equity inducement awards as required by the Nasdaq Stock Market Rules.

Okta, Inc. (Nasdaq: OKTA), the leading independent identity partner, today announced financial results for its fourth quarter and fiscal year ended January 31, 2026.

HeartBeam, Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, will hold a conference call on Thursday, March 12, 2026 at 4:30 p.m. Eastern time to discuss its results for the fourth quarter and full year ended December 31, 2025, and will be providing updates on its key strategic growth initiatives, specifically the limited commercial launch and significant developments on the 12-lead ECG extended wear patch. A press release detailing these results will be issued prior to the call.

Mechelen, Belgium; March 4, 2026, 22:01 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) received transparency notifications from Bank of America.

EMERYVILLE, Calif., March 04, 2026 (GLOBE NEWSWIRE) -- Grocery Outlet Holding Corp. (NASDAQ: GO) ("Grocery Outlet," the "Company," "we" or "our") today announced financial results for the fourth quarter and full fiscal year ended January 3, 2026, both of which contained one additional week ("53rd week") versus the comparable prior periods. Additionally, the Company today announced a business optimization plan (the “Optimization Plan”) to improve operational execution, strengthen long-term profitability and increase cash flow generation.

BOSTON, March 04, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (Nasdaq: PRAX), a fully integrated, leading central nervous system (CNS) precision neuroscience biopharmaceutical company, today announced that on March 2, 2026, the Compensation Committee of Praxis’ Board of Directors granted restricted stock unit awards covering an aggregate of 2,931 shares of its common stock to fourteen new non-executive employees under the Praxis Precision Medicines, Inc. 2024 Inducement Plan (the 2024 Inducement Plan). The restricted stock unit awards were granted as inducements material to the employees’ entering into employment with Praxis in accordance with Nasdaq Listing Rule 5635(c)(4).

NEW YORK, March 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that on March 1, 2026, the Company granted inducement awards to purchase up to 81,600 shares of common stock to three new employees under the Company's 2023 Inducement Plan. The stock options will vest over four years, with 25% of the underlying shares vesting on the one-year anniversary of the vesting commencement date and 1/48th of the underlying shares vesting monthly thereafter over 36 months, subject to the employee's continued service relationship with Syndax through the applicable vesting dates.

WARREN, N.J., March 04, 2026 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company advancing medicines to bring meaningful improvement to patients' lives through innovative science and delivery technologies, today reported financial results for the fourth quarter and full year ended December 31, 2025, and provided a progress update on the Company's key 2026 objectives.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.